<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药渡 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T11:13:00+08:00</updated>
  <subtitle>药渡以自有药物大数据为依托，对上市及临床在研药物、药物研究进展和重要药物市场商业动态作出信息整合分析，传递药物创新一手资讯</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重大进展！山东大学易凡团队鉴定了糖尿病性肾脏疾病的潜在治疗新靶点</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Nr2Z05TcIwZpFZI0uoUvxQ</id>
    <link href="https://mp.weixin.qq.com/s/Nr2Z05TcIwZpFZI0uoUvxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>挚盟医药抗乙肝病毒核衣壳抑制剂ZM-H1505R获批临床</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/WdiC4IYwQxezDoU_vLsEdA</id>
    <link href="https://mp.weixin.qq.com/s/WdiC4IYwQxezDoU_vLsEdA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/zdPHgofoJxj0Kc7NTByQvQ</id>
    <link href="https://mp.weixin.qq.com/s/zdPHgofoJxj0Kc7NTByQvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020新原力论坛圆满落幕，千名科学家、企业家、艺术家、公益家齐聚一堂</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/ML481sqnhHRQ35N3_BulfA</id>
    <link href="https://mp.weixin.qq.com/s/ML481sqnhHRQ35N3_BulfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>征文 | 第三届金笔奖评选火热报名中！丰厚稿酬鼓励制药撰稿人</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/QQpLwo-b2DTM_LCung22rw</id>
    <link href="https://mp.weixin.qq.com/s/QQpLwo-b2DTM_LCung22rw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/e1ZrHNAvb3zTevY8Fs24-A</id>
    <link href="https://mp.weixin.qq.com/s/e1ZrHNAvb3zTevY8Fs24-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>阿斯利康热销药品被重点监控，你家的品种还好吗？</title>
    <updated>2020-11-16T22:54:48+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/BgjTnXxZxRzkBs07eBW7Mw</id>
    <link href="https://mp.weixin.qq.com/s/BgjTnXxZxRzkBs07eBW7Mw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一病一图 | 库欣综合征新疗法-Osilodrostat获FDA/EMA双批准</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/c9F4siH0ewHCcO7aL874mg</id>
    <link href="https://mp.weixin.qq.com/s/c9F4siH0ewHCcO7aL874mg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费入场券！ | 40+行业领袖齐聚，12月千人生物工艺盛会等你来撩！</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/kJxRN9zDYpEjZ2UVISAnTA</id>
    <link href="https://mp.weixin.qq.com/s/kJxRN9zDYpEjZ2UVISAnTA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/thZa37ttxjil_lhjaCMYJA</id>
    <link href="https://mp.weixin.qq.com/s/thZa37ttxjil_lhjaCMYJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/v3_BAR3H0DJzBFw71E1eNA</id>
    <link href="https://mp.weixin.qq.com/s/v3_BAR3H0DJzBFw71E1eNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 咨询合伙人</title>
    <updated>2020-11-15T16:51:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/x3TOYhHaGzgwAJy1cK_OlQ</id>
    <link href="https://mp.weixin.qq.com/s/x3TOYhHaGzgwAJy1cK_OlQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>曙光乍现—KRAS G12C明星抑制剂的进击之路</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/i3FItSjdENSJr1qqHPW5Tw</id>
    <link href="https://mp.weixin.qq.com/s/i3FItSjdENSJr1qqHPW5Tw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【抗体盛会·限量免费】抗体药物开发及产业化峰会·2021</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/G9d2QVhtzOCp8Uh-bnrL1g</id>
    <link href="https://mp.weixin.qq.com/s/G9d2QVhtzOCp8Uh-bnrL1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/sTENHEoZL-T1PHXQtrBWnA</id>
    <link href="https://mp.weixin.qq.com/s/sTENHEoZL-T1PHXQtrBWnA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡书店 | 狂欢钜惠：超值半价，买1送1</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/_cYezWHh3iSZbSUhEKaWVQ</id>
    <link href="https://mp.weixin.qq.com/s/_cYezWHh3iSZbSUhEKaWVQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药渡招聘 | 客户经理</title>
    <updated>2020-11-14T21:08:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/zIfNBuQQwoSQYoNzWz6PeQ</id>
    <link href="https://mp.weixin.qq.com/s/zIfNBuQQwoSQYoNzWz6PeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>聚焦药靶 | MRD在血液肿瘤临床研究进展及伴随诊断解决方案</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/28M3mRroawOYciqL11UMaQ</id>
    <link href="https://mp.weixin.qq.com/s/28M3mRroawOYciqL11UMaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品不良反应97.7%？君实生物PD-1副作用到底几何？</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/VcVWKSl5cCKdROR05sdb6g</id>
    <link href="https://mp.weixin.qq.com/s/VcVWKSl5cCKdROR05sdb6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【11月17号】抗肿瘤药临床试验影像终点程序标准技术指导原则与FDA&amp;CDE 指南的比较及Recist 1.1用于实体瘤疗效评估</title>
    <updated>2020-11-13T18:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/xTNbiChJd3vLbYTX3QUP5w</id>
    <link href="https://mp.weixin.qq.com/s/xTNbiChJd3vLbYTX3QUP5w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>